Cronos Group Inc. - Common Share (CRON) Company Bio
Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.
Shares of Canada's leading cannabis producer, Canopy Growth (NYSE:CGC), plunged Friday after the company reported dismal fourth-quarter numbers which fell far short of expectations. CGC stock is down more than 18%.Source: Shutterstock The steep drop in Canopy Growth stock makes complete sense. The quarter was bad. And it was totally unexpected.While cannabis peers like Cronos (NASDAQ:CRON) and Aurora Cannabis (NYSE:ACB) reported strong numbers over the past month -- which broadly included accelerating revenue growth and narrowing losses -- Canopy's fourth-quarter numbers were the exact opposite.InvestorPlace - Stock Market News, Stock Advice & Trading TipsRevenues dropped 13% sequentially, and its adjusted earnings before interest, taxes, deprecation and amortization (EBITDA) loss expan...
The webcasts will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations. Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.